Fischer Medical Ventures Limited share price

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

• Fischer Medical Ventures Limited is in the Medical Devices industry (Healthcare), with a market value of ₹2,072 crore.
• It trades at 12.7 times its last 12 months' earnings and 5.0 times book value.
• Revenue grew 1,097.9% a year over the last 4 years.
• Return on equity was 8.6% and return on capital employed 12.5% in the latest year.
• Debt was 0.28 times shareholders' equity.
• The share price is 75.6% below its 52-week high and down 68.9% over one year.
• Promoters and insiders hold about 77.3%; institutions about 2.8%.

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.

Employees

16

Head office

Chennai

Consolidated figures in ₹ crore / View Standalone

Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Latest quarter on the right.

Consolidated figures in ₹ crore / View Standalone

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Consolidated figures in ₹ crore, as at 31 March

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Consolidated figures in ₹ crore, financial years ending March

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Numbers in percentages · as filed with NSE each quarter

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Filings made by the company with NSE; documents open on NSE's website.

Ex-dividend date

22 Sep 2026

Latest quarter

30 Jun 2026

Financial year end

31 Mar 2026

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.